-
Posted by
Two Blokes Jun 26 -
Filed in
Stock
-
5 views
LifeMD is a fast-growing, profitable telehealth company with strong partnerships, a robust tech stack and a valuable SaaS asset. The Novo Nordisk/Hims fallout is bullish, not bearish, for LifeMD. Novo Nordisk and Eli Lilly are unlikely to break a partnership with LifeMD. Q1 2025 results showed an excellent inflection into profitability, but guidance was conservative and gross margins declined due to product mix.
